Strides Pharma Science receives NCLT approval
For merger of wholly owned subsidiaries
Strides Pharma Science has received the approval from the Hon'ble National Company Law Tribunal, Mumbai Bench for approval of the Scheme of Amalgamation of Arrow, Fagris, and SEML with the Company and their respective shareholders and creditors (Scheme) pursuant to the provisions of Sections 230-232 and other applicable provisions of the Companies Act, 2013.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content